Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR
Fingerprint
Dive into the research topics where Jing Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets
Xiong, Y., Zhong, Y., Yim, H., Yang, X., Park, K. S., Xie, L., Poulikakos, P. I., Han, X., Xiong, Y., Chen, X., Liu, J. & Jin, J., 14 Dec 2022, In: Journal of the American Chemical Society. 144, 49, p. 22622-22632 11 p.Research output: Contribution to journal › Article › peer-review
-
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Li, D., Yu, X., Kottur, J., Gong, W., Zhang, Z., Storey, A. J., Tsai, Y. H., Uryu, H., Shen, Y., Byrum, S. D., Edmondson, R. D., Mackintosh, S. G., Cai, L., Liu, Z., Aggarwal, A. K., Tackett, A. J., Liu, J., Jin, J. & Wang, G. G., 10 Jun 2022, In: Oncogene. 41, 24, p. 3328-3340 13 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Discovery of Potent, Selective, and in Vivo Efficacious AKT Kinase Protein Degraders via Structure-Activity Relationship Studies
Yu, X., Xu, J., Shen, Y., Cahuzac, K. M., Park, K. S., Dale, B., Liu, J., Parsons, R. E. & Jin, J., 24 Feb 2022, In: Journal of Medicinal Chemistry. 65, 4, p. 3644-3666 23 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Discovery of the First-in-Class G9a/GLP Covalent Inhibitors
Park, K. S., Xiong, Y., Yim, H., Velez, J., Babault, N., Kumar, P., Liu, J. & Jin, J., 11 Aug 2022, In: Journal of Medicinal Chemistry. 65, 15, p. 10506-10522 17 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras
Yu, X., Cheng, M., Lu, K., Shen, Y., Zhong, Y., Liu, J., Xiong, Y. & Jin, J., 23 Jun 2022, In: Journal of Medicinal Chemistry. 65, 12, p. 8416-8443 28 p.Research output: Contribution to journal › Article › peer-review
Press / Media
-
US Patent Issued to Icahn School of Medicine at Mount Sinai on Jan. 3 for "Compositions and methods for treating CDK4/6-mediated cancer" (New York, New Jersey Inventors)
Tamer Ahmed, Zoi Karoulia, XUEWEI WU , Yan Xiong , Poulikos Poulikakos, Jing Liu & Jian Jin
21/01/23
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in New Jersey (Jan. 5)
Tamer Ahmed, Zoi Karoulia, XUEWEI WU , Yan Xiong , Yang Yang, Poulikos Poulikakos, Jing Liu & Jian Jin
5/01/23
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in New York (Jan. 5)
Tamer Ahmed, Zoi Karoulia, XUEWEI WU , Yan Xiong , Arvind Kumar, Poulikos Poulikakos, Jing Liu & Jian Jin
5/01/23
1 item of Media coverage
Press/Media
-
Compositions and Methods for Treating CDK4/6-mediated Cancer
Tamer Ahmed, Zoi Karoulia, XUEWEI WU , Yan Xiong , Poulikos Poulikakos, Jing Liu & Jian Jin
3/01/23
1 item of Media coverage
Press/Media
-
US Patent Issued to Icahn School of Medicine at Mount Sinai on Oct. 18 for "Serine threonine kinase (AKT) degradation / disruption compounds and methods of use" (New York Inventors)
Xufen Yu, Jing Liu, Ramon Parsons & Jian Jin
19/10/22
1 item of Media coverage
Press/Media